Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Haematologica|October 3, 2009
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOPJesse Shustik, Guangming Han, Pedro Farinha, et al.Journal of Environmental Management|October 28, 2025
Microbial mechanisms of biochar reducing methane emission in a rice-crayfish integrated systemLinjie Ma, Chengxin Zhang, Baoli Qin, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 6, 2013
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumorsAlon D Altman, Gregg S Nelson, Prafull Ghatage, et al.International Journal of Surgical Pathology|January 18, 2018
Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous CarcinomaDina Bassiouny, Nadia Ismiil, Valerie Dubé, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 9, 2008
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 lossBlaise Clarke, Anna V Tinker, Cheng-Han Lee, et al.American Journal of Obstetrics and Gynecology|June 26, 2010
Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma riskMario M Leitao, Guangming Han, Lisa X Lee, et al.Frontiers in Oncology|September 2, 2024
Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomesGurdial Dhillon, Marta Llaurado-Fernandez, Basile Tessier-Cloutier, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 31, 2018
Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic CharacteristicsDina Bassiouny, Mahmoud A El-Baz, Tawakol M Gamil, et al.Gynecologic Oncology|February 9, 2016
Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)Marcus Q Bernardini, Lilian T Gien, Susie Lau, et al.The American Journal of Surgical Pathology|October 1, 2013
Histotype-genotype correlation in 36 high-grade endometrial carcinomasLien N Hoang, Melissa K McConechy, Martin Köbel, et al.Pageof 5